AKT1 and neoplasm: Cell experiments suggest that KRT17 knockout could inhibit the proliferation and migration of GC cells, which may be achieved through the Akt/mTOR signalling pathway, and animal experiments also confirmed that KRT17 knockout could inhibit tumour growth (Chivu-Economescu et al., 2017).